Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Adamis Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€0.047
29.05.23
-
29.05.24
0.00%
02:15

StockNews.com 
29.05.23 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.53
29.05.23
-
29.05.24
-18.87%
02:15

StockNews.com 
29.05.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.48
28.05.23
-
28.05.24
-60.91%
29.05.24

StockNews.com 
28.05.23 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€20.40
28.05.24
€38.00
30.06.26
109.80%
28.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
28.05.24 50%
sell
Insmed Inc.

Start price
Target price
Perf. (%)
€20.40
26.05.24
€16.00
31.01.26
0.00%
28.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
26.05.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
€6.00
31.07.27
-44.67%
26.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
sell
Insmed Inc.

Start price
Target price
Perf. (%)
€22.80
17.05.24
€18.00
28.02.26
-10.53%
26.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.05.24 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
25.05.23
-
25.05.24
-
26.05.24

StockNews.com 
25.05.23 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.82
25.05.23
-
25.05.24
50.75%
26.05.24

Oppenheimer Holdings Inc. 
25.05.23 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€5.80
29.11.23
-
29.11.24
-28.62%
25.05.24

Could be very worthwhile Investment >20% year
blaugold 
29.11.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€397.00
24.05.23
€464.75
24.05.24
88.34%
25.05.24

Bank of America Co. 
24.05.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€397.00
24.05.23
€462.89
24.05.24
88.34%
25.05.24

UBS Group AG 
24.05.23 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€12.15
13.05.24
-
13.05.25
16.83%
25.05.24

Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
kostojunior 
13.05.24 80%
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€1.44
22.05.23
-
22.05.24
-39.35%
23.05.24

Robert W. Baird 
22.05.23 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.60
21.05.23
-
21.05.24
-27.73%
22.05.24

StockNews.com 
21.05.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
20.05.23
-
20.05.24
-
21.05.24

StockNews.com 
20.05.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.05
20.05.23
-
20.05.24
-63.97%
21.05.24

StockNews.com 
20.05.23 50%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.88
19.05.23
€3.00
19.05.24
-61.56%
20.05.24

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
19.05.23 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€8.70
11.05.24
€82.00
11.05.25
39.26%
19.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
mixitrader 
11.05.24 50%
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€17.30
18.05.23
-
18.05.24
31.79%
19.05.24

TD Cowen 
18.05.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€34.10
18.05.23
-
18.05.24
-22.43%
19.05.24

Cantor Fitzgerald 
18.05.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€34.10
18.05.23
-
18.05.24
-22.43%
19.05.24

Cantor Fitzgerald 
18.05.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€73.00
16.05.23
€91.88
16.05.24
-14.51%
17.05.24

BMO Capital Markets 
16.05.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€73.00
16.05.23
€91.88
16.05.24
-14.51%
17.05.24

BMO Capital Markets 
16.05.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€73.00
16.05.23
€91.88
16.05.24
-14.51%
17.05.24

BMO Capital Markets 
16.05.23 50%